In this neuropathological study, we investigated neuroinflammation surrounding recent and old cerebral microbleeds (CMBs) and cerebral microinfarcts (CMIs) in 18 cases of cerebral amyloid angiopathy (CAA). We used several serial stainings and immunolabellings to identify microvascular lesions, define their recent or old stage, and characterize neuroinflammatory response (scavenging activity and astrogliosis). We found that both CMBs and CMIs induce a neuroinflammatory response, which was more pronounced in old lesion than recent. Astrogliosis and scavenging activity were differentially prominent according to the ischemic/hemorrhagic nature of the lesion. Our findings provide insights into the pathophysiology of microvascular injuries in CAA.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/acn3.52226 | DOI Listing |
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11651216 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Prevalence and associations of cerebral microbleeds in an Australian memory clinic cohort.
Intern Med J
December 2024
Medical and Cognitive Research Unit, Department of Geriatric Medicine, Austin Health, Melbourne, Victoria, Australia.
Background: Cerebral microbleeds (CMBs) are small brain haemorrhages, identified by magnetic resonance imaging (MRI). They indicate potential for cognitive decline and mortality in memory clinic attendees. The presence of more than four CMBs is exclusionary for some clinical trials of disease-modifying therapies for Alzheimer's disease (AD).
View Article and Find Full Text PDFComprehensive predictive model for cerebral microbleeds: integrating clinical and biochemical markers.
Front Neurosci
December 2024
Department of Neurology, Affiliated Hospital of Hebei University, Baoding, China.
Background: Cerebral Microbleeds (CMBs) serve as critical indicators of cerebral small vessel disease and are strongly associated with severe neurological disorders, including cognitive impairments, stroke, and dementia. Despite the importance of diagnosing and preventing CMBs, there is a significant lack of effective predictive tools in clinical settings, hindering comprehensive assessment and timely intervention.
Objective: This study aims to develop a robust predictive model for CMBs by integrating a broad range of clinical and laboratory parameters, enhancing early diagnosis and risk stratification.
SHIVA-CMB: a deep-learning-based robust cerebral microbleed segmentation tool trained on multi-source T2*GRE- and susceptibility-weighted MRI.
Sci Rep
December 2024
GIN, IMN-UMR5293, CEA, CNRS, Université de Bordeaux, Bordeaux, France.
Cerebral microbleeds (CMB) represent a feature of cerebral small vessel disease (cSVD), a prominent vascular contributor to age-related cognitive decline, dementia, and stroke. They are visible as spherical hypointense signals on T2*- or susceptibility-weighted magnetic resonance imaging (MRI) sequences. An increasing number of automated CMB detection methods being proposed are based on supervised deep learning (DL).
View Article and Find Full Text PDFImpact of Small Vessel Disease on Patient Outcomes Following Intravenous Thrombolysis For Acute Ischemic Stroke.
Am J Cardiol
December 2024
Jinan Hospital, 63-1 Lishan Road, Jinan City 250013.
Individual cerebral small vessel disease (SVD) markers independently predict poor prognosis following stroke. However, the impact of a single SVD, especially cumulative SVD burden on outcomes in acute ischemic stroke (AIS) after intravenous thrombolysis remains unclear. This work evaluated the occurrence of small vessel disease (SVD) in AIS patients who were treated with intravenous thrombolytic therapy by using multimodal MRI imaging.
View Article and Find Full Text PDFPrognostic study of intracranial branch atheromatous disease in the blood-supplying areas of the lenticulostriate and paramedian pontine arteries.
J Stroke Cerebrovasc Dis
December 2024
Department of Neurology, the Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang 150000, China.. Electronic address:
Introduction: Branch atheromatous disease (BAD) is prone to early neurological deterioration (END), leading to a poor prognosis. The most common arteries causing END are the lenticulostriate arteries (LSA) and the paramedian pontine arteries (PPA). To gain insight into the characteristics of symptomatic plaques and their association with poor prognosis in patients with BAD, we conducted a prospective study using high-resolution magnetic resonance imaging (HRMRI).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!